Ellevest Inc’s Aimmune Therapeutics AIMT Stock Holding History

Ellevest Inc’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-44	Closed	-$2K	–	1441
2020 Q3	$2K	Buy	+44	New	+$937	﹤0.01%	953

Ellevest Inc's AIMT Position: Q4 2020 in Review

Ellevest Inc sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 44 shares — an estimated $2K sold.

Ellevest Inc first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Ellevest Inc reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Ellevest Inc sold 44 Aimmune Therapeutics shares in Q4 2020, an estimated $2K.
Ellevest Inc first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Ellevest Inc's Aimmune Therapeutics position peaked at $2K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Ellevest Inc's 13F filing for Q4 2020, filed 4 Feb 2021.